Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby et al., The Lancet, doi:10.1016/S0140-6736(20)32013-4
https://c19early.org/horby2.html